The U.S. Food and Drug Administration (FDA) decision to regulate laboratory diagnostic tests (LDTs) is gaining momentum, but also facing much criticism.   The FDA recently informed Congress of their intent to regulate LDTs, which previously did not require FDA approval. The FDA has yet to release their draft guidance documents, but they are on track … Continue reading →